5月6日 - ** 生物技术公司Bio-Techne TECH.O股价下跌12.8%，报49.42美元
** 据LSEG数据显示， (link) 公司公布第一季度营收为3.114亿美元，低于分析师预期的3.171亿美元
** TECH旗下最大的蛋白质科学部门销售额下降1%，至2.262亿美元
** Leerink Partners表示：“我们预计市场将对TECH的财报数据作出负面反应，且关注焦点将集中在TECH能否在2026财年实现中个位数的增长”
** Evercore ISI预计，受生物技术融资复苏的推动，2027财年业绩将出现反弹
** 该公司本季度经调整后每股收益为53美分，低于54美分的预期
** 计入当日跌幅，TECH今年以来累计下跌15.4%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.